Dr. Mehmet Oz on Falling Drug Prices and Healthcare Costs

Dr. Mehmet Oz, Administrator of the Centers for Medicare and Medicaid Services, discussed the ongoing concerns about rising healthcare costs in the United States. He acknowledged that healthcare expenses are a significant economic worry for Americans, particularly with cost projections for 2027.

“

Well, I think drug prices are going to continue to drop. This is just what the doctor ordered.

Oz highlighted a positive development: a 3.1% year-over-year decrease in drug prices for July, as reported by the Consumer Price Index. He described this as the fastest drop in 63 years and expressed confidence that prices will continue to decline. This trend is crucial for alleviating the financial burden on individuals who often struggle to afford prescribed medications.

“

One in three times, roughly, you will leave empty-handed because you can't afford the medication.

He explained that the administration's efforts, driven by President's mandate, aim to address the disparity in drug pricing compared to other countries. The "Most-Favored-Nation Drug Pricing" policy ensures that companies charge U.S. consumers rates comparable to those in Europe or Asia, preventing excessive domestic pricing.

“

The real question is why didn't we deal with it earlier?

Oz noted that 17 companies, representing 85% of the drug sector, have agreed to these terms. He added that this stabilization has been positively received by the market, with participating companies seeing an increase in their market capitalization on Wall Street.

“

I don't want you to hurt productivity, creativity, innovation in the pharmaceutical sector, but they are not allowed to charge three times more for the exact same products made often in U.S. facilities than they pay in Europe or Asia.